Opioid-Sparing Solutions: The Rise of the Intravenous Ibuprofen Market in Acute Pain and Fever Management
Description
An investigation into the rapid growth of the Intravenous Ibuprofen Market, driven by the crucial need for opioid-sparing pain management protocols, its use in surgical and critical care settings, and the high CAGR reflecting the global shift toward multimodal analgesia.
The Intravenous Ibuprofen Market is experiencing dynamic growth as a key player in the shift toward non-opioid pain management strategies in surgical and critical care. The market was valued at $7.29 billion in 2024 and is projected to reach $11.84 billion by 2032, growing at a CAGR of 6.25%. The primary driver is the rising demand for effective, rapid-onset pain relief and fever management in hospitals and ambulatory surgical centers.
IV ibuprofen is widely adopted in multimodal analgesia protocols and Enhanced Recovery After Surgery (ERAS) pathways, helping to reduce reliance on prescription opioids and their associated…